Your browser doesn't support javascript.
loading
Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer.
Sonnenblick, Amir; Salmon-Divon, Mali; Salgado, Roberto; Dvash, Efrat; Pondé, Noam; Zahavi, Tamar; Salmon, Asher; Loibl, Sibylle; Denkert, Carsten; Joensuu, Heikki; Ameye, Lieveke; Van den Eynden, Gert; Kellokumpu-Lehtinen, Pirkko-Liisa; Azaria, Amos; Loi, Sherene; Michiels, Stefan; Richard, François; Sotiriou, Christos.
Afiliación
  • Sonnenblick A; Institute of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Salmon-Divon M; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Salgado R; Department of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel, Israel.
  • Dvash E; Department of Pathology, GZA-ZNA, Antwerp, Belgium.
  • Pondé N; Division of Research, Peter Mac Callum Cancer Center, Melbourne, Australia.
  • Zahavi T; Institute of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Salmon A; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Loibl S; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Denkert C; Medical Oncology Department, AC Camargo Cancer Center, São Paulo, Brazil.
  • Joensuu H; Sharett Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
  • Ameye L; Sharett Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
  • Van den Eynden G; German Breast Group, Neu-Isenburg and Goethe University Frankfurt and Centre for Haematology and Oncology, Bethanien, Frankfurt, Germany.
  • Kellokumpu-Lehtinen PL; Institute of Pathology, Philipps-University Marburg and UKGM Marburg, Marburg, Germany.
  • Azaria A; Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Loi S; Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium.
  • Michiels S; Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Richard F; Department of Oncology, University of Tampere and Tampere University Hospital, Tampere, Finland.
  • Sotiriou C; Department of Computer Science, Ariel University, Ariel, Israel.
Int J Cancer ; 147(1): 266-276, 2020 07 01.
Article en En | MEDLINE | ID: mdl-31904863
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Trastuzumab Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Int J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Trastuzumab Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Int J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Israel